Edition:
United Kingdom

Carl O'Donnell

Sarepta shares fall 4% after FDA documents show safety concerns about drug

22 Jan 2020

Shares of Sarepta Therapeutics Inc were down around 4% Wednesday after the U.S. Food and Drug Administration revealed documents detailing concerns it had about the safety and efficacy of one of the company's recently approved Duchenne muscular dystrophy (DMD) drugs.

Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO

16 Jan 2020

SAN FRANCISCO Eli Lilly and Co aims to announce roughly one $1 billion to $5 billion deal every quarter in 2020, its chief financial officer told Reuters, as the U.S. drugmaker looks to build up its pipeline of future products.

Bristol-Myers confident of approvals linked to higher Celgene investor payout: Bristol executive

09 Jan 2020

NEW YORK Bristol-Myers Squibb Co is confident it will receive U.S. approvals for all three experimental drugs tied to a potentially higher payout for Celgene shareholders under terms of its acquisition of the U.S. biotech company, Bristol's chief medical officer said.

Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs

01 Jan 2020

NEW YORK Drugmakers including Pfizer Inc , GlaxoSmithKline PLC and Sanofi SA are planning to hike U.S. list prices on more than 200 drugs in the United States on Wednesday, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors.

Novartis wins Medicaid approval for new sickle cell drug in key U.S. states

20 Dec 2019

Novartis AG has secured Medicaid coverage for a pricey new sickle cell disease therapy in two U.S. states just weeks after winning U.S. approval, following an early campaign to convince local officials of its value, according to a company executive and a Reuters review of public filings.

Trump proposes rule for importing drugs from Canada; industry says it won't cut costs

19 Dec 2019

NEW YORK The Trump administration on Wednesday said it is proposing a rule to allow states to import prescription drugs from Canada, advancing a plan announced in July that the president has said will bring cheaper prescription drugs to Americans.

Trump administration moves forward rule to import medicines

18 Dec 2019

NEW YORK, Dec 18 The Trump administration on Wednesday said it is proposing a rule to allow states to import prescription drugs from Canada, moving forward a plan announced this summer that the president has said will bring cheaper prescription drugs to Americans.

J&J CEO spurns U.S. congressional hearing on carcinogens in talc products

10 Dec 2019

Johnson & Johnson Chief Executive Officer Alex Gorsky has declined to appear at a U.S. congressional hearing set for Tuesday on the safety of the company's Baby Powder and other talc-based cosmetics.

World News